유나이티드제약

033270KOSPI

58.5 / 100

Reference Date: 2026-10-23

Financial Score31.0 / 40

News Sentiment12.5 / 25

Momentum5.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but Operating Profit is on a declining trend. Slightly down 4.9% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

United Pharmaceutical is a specialized generic drug manufacturer focusing on improved drugs, achieving sales of 2.887 trillion won in 2024 with a 20% operating profit margin through key products like Silostan CR Tablets and Artmax Combi Gel. The company maintains advanced production facilities and R&D capabilities, exporting pharmaceuticals to over 40 countries and launching 17 improved drug formulations.

Number of Employees

902people

Average Salary

67.0M KRW

Score Calculation Basis

Detailed Financial Score

PER

6.56Industry Average 15.008.0Point

Half of industry avg (excellent)

PBR

0.60Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE

8.90Industry Average 8.004.0Point

In line with industry avg

Debt Ratio

3.76Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20254.0 / 10 points

Revenue Growth Rate

1.0 / 3

Avg ▲1.8% (2-year basis)

Operating Profit Growth Rate

0.5 / 3

Avg ▼4.7% (2-year basis)

ROE Trend

2.5 / 4

Avg ROE 10.2% (declining, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (11%, downtrend)

Current 17,160Won52-week high 21,40052-week low 16,600

1-month return2.0Point

1m -4.88% (slight drop)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

0 totalPositive 0Neutral 0Negative 0